Prostaglandin E1 in infants with congenital diaphragmatic hernia (CDH) and life-threatening pulmonary hypertension

Autor: Gilliot, Sixtine, Boukhris, Mohamed Riadh, Masse, Morgane, Storme, Laurent, Décaudin, Bertrand, Odou, Pascal, Le Duc, Kevin, Mur, Sébastien, Rakza, Thameur, Rousset, Céline, Vaast, Pascal, Westlynk, Nathalie, Aubry, Estelle, Sharma, Dyuti, Besengez, Capucine, Garabedian, Charles, de Jonckheere, Julien, Recher, Morgan

Publikováno v: Journal of Pediatric Surgery
Journal of Pediatric Surgery, 2020, 55 (9), pp.1872-1878. ⟨10.1016/j.jpedsurg.2020.01.008⟩
Journal of Pediatric Surgery, American Academy of Pediatrics, 2020, 55 (9), pp.1872-1878. ⟨10.1016/j.jpedsurg.2020.01.008⟩

Background Suprasystemic pulmonary hypertension (PH) is highly predictive of pulmonary morbidity and death in infants with congenital diaphragmatic hernia (CDH). Objectives To report the effects and tolerability of Prostaglandin E1 (PGE1) in newborns

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a9f6ac4c115fdc0ebafe644330907d
https://pubmed.ncbi.nlm.nih.gov/32061366